Bristol Myers Squibb (BMY)

EBITDA Growth

11.59%

TTM · Period ending:

BMY logo

BMY EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported11.59%
BMY TTM EBITDA YoY % (20.65% → 11.59%)
High-resolution chart · PNG

BMY ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Bristol Myers Squibb EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
4.8854%
8.6639%
8.7018%
12.0092%
8.4724%
8.1959%
10.5987%
10.7648%
14.2377%
14.0718%
14.2573%
13.6092%
13.703%
13.5848%
12.4553%
9.4659%
9.567%
9.2425%
10.0665%
15.3966%
14.377%
14.6995%
14.4507%
32.953%
32.4868%
32.3689%
30.948%
23.2211%
21.6216%
20.7951%
20.2217%
-23.8482%
-23.5236%
-25.0246%
-25.1328%
6.02%
7.5512%
10.8167%
14.3942%
179.7094%
234.7599%
624.7619%
143.121%
-266.9108%
-202.0378%
-127.3723%
-38.8136%
-1.2429%
8.1322%
13.1897%
20.6544%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.